2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Position Statement on the Management of Ventricular Tachycardia and Fibrillation in Patients With Structural Heart Disease-Reference-Cited by-同舟云学术

2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Position Statement on the Management of Ventricular Tachycardia and Fibrillation in Patients With Structural Heart Disease

Published:2020-06 Issue:6 Volume:36 Page:822-836
ISSN:0828-282X
Container-title:Canadian Journal of Cardiology
language:en
Short-container-title:Canadian Journal of Cardiology

Author:

Deyell Marc W.,AbdelWahab Amir^ORCID,Angaran Paul,Essebag Vidal,Glover Ben,Gula Lorne J.,Khoo Clarence,Lane Christopher,Nault Isabelle^ORCID,Nery Pablo B.^ORCID,Rivard Lena,Slawnych Michael P.,Tulloch Heather L.,Sapp John L.

Funder

Canadian Cardiovascular Society

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference94 articles.

1. Canadian Cardiovascular Society/Canadian Heart Rhythm Society 2016 implantable cardioverter-defibrillator guidelines;Bennett;Can J Cardiol,2017

2. Arrhythmias in adults with congenital heart disease: what the practicing cardiologist needs to know;Khairy;Can J Cardiol,2019

3. PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease

4. Part 1: executive summary: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care;Neumar;Circulation,2015

5. ACC/AHA/HRS 2006 Key Data Elements and Definitions for Electrophysiological Studies and Procedures

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A randomized clinical trial of catheter ablation and antiarrhythmic drug therapy for suppression of ventricular tachycardia in ischemic cardiomyopathy: The VANISH2 trial;American Heart Journal;2024-08

2. Catheter ablation versus antiarrhythmic drug therapy for sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy;BMC Cardiovascular Disorders;2024-05-16

3. Role of Nuclear Imaging in Cardiac Stereotactic Body Radiotherapy for Ablation of Ventricular Tachycardia;Seminars in Nuclear Medicine;2024-05

4. Relevance of mexiletine in the era of evolving antiarrhythmic therapy of ventricular arrhythmias;Clinical Research in Cardiology;2024-02-14

5. Ventricular Tachycardia Catheter Ablation: Retrospective Analysis and Prospective Outlooks—A Comprehensive Review;Biomedicines;2024-01-24